Alector ALEC
NASDAQ ALEC
$2.46 -0.05 (-1.99%)
At close: Sep 4, 2026 · 4:00 PM EDT

Alector (ALEC) Capital Expenditures (2018 - 2026)

Alector's (ALEC) quarterly Capital Expenditures came in at $31000.0 in Q2 2026, up 210.0% year-over-year from $10000.0 in Q2 2025, and down 73.73% quarter-over-quarter from $118000.0 in Q1 2026.

Analysis

Alector (ALEC) Capital Expenditures (2018 - 2026) Analysis & Trends

Alector (ALEC) has reported Capital Expenditures for 9 consecutive years, with $31000.0 the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Capital Expenditures rose 210.0% year-over-year to $31000.0 in Q2 2026; TTM through Jun 2026 was $160000.0, a 61.45% decrease from a year earlier, with the FY2025 full-year figure at $41000.0, down 96.73% from the prior year.
  • Capital Expenditures was $31000.0 for Q2 2026 at Alector, down from $118000.0 in the prior quarter.
  • Over five years, Capital Expenditures peaked at $1.9 million in Q3 2022 and troughed at -$94000.0 in Q3 2023.
  • A 5-year average of $467235.3 and a median of $233000.0 in 2023 frame the typical range for Capital Expenditures.
  • Across the five-year window, Capital Expenditures slumped 104.91% in 2023 and jumped 490.0% in 2026, its largest moves.
  • Over 5 years, Capital Expenditures stood at $766000.0 in 2022, then tumbled by 69.58% to $233000.0 in 2023, then decreased by 25.75% to $173000.0 in 2024, then slumped by 93.64% to $11000.0 in 2025, then surged by 181.82% to $31000.0 in 2026.
  • The last three Capital Expenditures figures came in at $31000.0 (Q2 2026), $118000.0 (Q1 2026), and $11000.0 (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capital Expenditures (Qtr)
1 Amgen 236.37 Bn 222.38 Bn 7.24 Bn 513.00 Mn
2 Gilead Sciences 187.38 Bn 184.12 Bn 6.22 Bn 140.00 Mn
3 Vertex Pharmaceuticals 138.36 Bn 130.51 Bn 2.84 Bn 112.20 Mn
4 Regeneron Pharmaceuticals 85.09 Bn 77.10 Bn 3.93 Bn 240.20 Mn
5 Argenx Se 63.93 Bn 58.75 Bn 1.37 Bn -
6 Moderna 58.07 Bn 52.94 Bn 52.00 Mn 37.00 Mn
7 Alnylam Pharmaceuticals 35.59 Bn 32.28 Bn 992.69 Mn 34.68 Mn
8 Biogen 32.63 Bn 31.34 Bn 1.96 Bn 40.90 Mn
9 Insmed 27.57 Bn 26.41 Bn 358.27 Mn 6.26 Mn
10 Alector 274.68 Mn 101.88 Mn - 31,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 31,000.00
Mar 31, 2026 118,000.00
Sep 30, 2025 11,000.00
Jun 30, 2025 10,000.00
Mar 31, 2025 20,000.00
Dec 31, 2024 173,000.00
Sep 30, 2024 212,000.00
Jun 30, 2024 337,000.00
Mar 31, 2024 533,000.00
Dec 31, 2023 233,000.00
Sep 30, 2023 -94,000.00
Jun 30, 2023 1.22 Mn
Mar 31, 2023 1.03 Mn
Dec 31, 2022 766,000.00
Sep 30, 2022 1.92 Mn
Jun 30, 2022 744,000.00
Mar 31, 2022 692,000.00
Dec 31, 2021 557,000.00
Sep 30, 2021 915,000.00
Jun 30, 2021 828,000.00